State Street Corp Ngm Biopharmaceuticals Inc Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.17 - $1.92 $833 - $1,367	712 Added 0.09%	823,111 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $16,725 - $36,517	27,876 Added 3.51%	822,399 $707,000
Q3 2023 Nov 14, 2023	SELL	$1.05 - $3.37 $65,145 - $209,084	-62,043 Reduced 7.24%	794,523 $850,000
Q2 2023 Aug 14, 2023	BUY	$2.44 - $4.53 $286,002 - $530,979	117,214 Added 15.85%	856,566 $2.22 Million
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $129,459 - $187,925	34,801 Added 4.94%	739,352 $3.02 Million
Q4 2022 Feb 14, 2023	SELL	$3.41 - $12.93 $514,991 - $1.95 Million	-151,024 Reduced 17.65%	704,551 $3.54 Million
Q3 2022 Nov 15, 2022	BUY	$12.59 - $17.67 $1.07 Million - $1.5 Million	85,133 Added 11.05%	855,575 $11.2 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $835,142 - $1.38 Million	78,936 Added 11.42%	770,442 $9.88 Million
Q1 2022 May 16, 2022	BUY	$13.81 - $18.6 $222,700 - $299,943	16,126 Added 2.39%	691,506 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $935,785 - $1.19 Million	54,217 Added 8.73%	675,380 $12 Million
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $534,881 - $695,213	26,545 Added 4.46%	621,163 $13.1 Million
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $1.61 Million - $3.21 Million	106,936 Added 21.93%	594,618 $11.7 Million
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $561,750 - $717,754	22,479 Added 4.83%	487,682 $14.2 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $380,983 - $738,934	23,503 Added 5.32%	465,203 $14.1 Million
Q3 2020 Nov 10, 2020	SELL	$15.59 - $19.97 $357,416 - $457,832	-22,926 Reduced 4.93%	441,700 $7.03 Million
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $66,720 - $130,821	5,574 Added 1.21%	464,626 $9.17 Million
Q1 2020 May 11, 2020	BUY	$10.0 - $19.51 $4.59 Million - $8.96 Million	459,052 New	459,052 $5.66 Million

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account